Content related to Finding New Combination Therapies for Neuroblastoma

Neuroblastoma cells under a microscope labeled with fluorescent molecules. Image courtesy of Shutterstock. Building upon more than two decades of basic research conducted at Children’s Hospital Los

A recent study found that the growth factor G-CSF, used in high-risk neuroblastoma treatment, leads to increased tumor growth and metastasis. Investigators think the benefits still outweigh the risks.

Investigators at The Saban Research Institute of Children’s Hospital Los Angeles have developed and tested a new biomarker assay for quantifying disease and detecting the presence of neuroblastoma

Yves De Clerck, MD

Children’s Hospital Los Angeles is the only hospital in Southern California where patients can receive MIBG therapy, a specialized targeted radiation therapy for neuroblastoma.

A neuroblastoma expert answers questions about how MIBG therapy works and what families can expect from this specialized radiation treatment available at CHLA.